Chad

in page functions
[French]
Chad
Total population (2017) 14,965,458
Birth cohort (2017) 657,823
Surviving Infants (surviving to 1 year per year, 2017) 600,195
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 85/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 139/1000
World Bank Index, IDA (2015) 2.78
Gross Nation Income (per capita US$, 2015) 880
Co-financing group (2017) Initial self-financing
No. of districts/territories (2015) 84

Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for Chad

Type of support

Approvals

2001-2021 (US$)
(25 Apr 2017)

Commitments

2001-2021 (US$)
(25 Apr 2017)

Disbursements

2000-2017 (US$)
(25 Apr 2017)

% Disbursed

(25 Apr 2017)
2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019
Total $65,778,446 $66,756,946 $61,882,872
Health system strengthening (HSS 1) $4,978,010 $4,978,010 $4,978,010 100%
Immunisation services support (ISS) $2,637,000 $2,637,000 $2,637,000 100%
Injection Safety Devices (NVS) $110,500 $110,500 $145,223 131%
Injection safety support (INS) $443,812 $443,812 $443,812 100%
IPV (NVS) $3,056,498 $3,056,498 $2,157,269 71%
Measles SIA (NVS) $2,111,229 $2,111,229 $2,111,229 100%
Measles SIA - Operational costs (OPC) $2,923,031 $2,923,031 $2,923,031 100%
Meningitis A (NVS) $544,000 $1,522,500 $475,839 87%
Meningitis A - campaign (NVS) $5,491,027 $5,491,027 $5,491,027 100%
Meningitis A - mini catch-up campaign (NVS) $2,946,000 $2,946,000 $2,966,158 101%
Meningitis A - mini catch-up op.costs (OPC) $2,283,500 $2,283,500
Meningitis A - operational costs (OPC) $3,712,275 $3,712,275 $3,712,275 100%
Penta (NVS) $28,124,029 $28,124,029 $27,590,417 98%
Vaccine Introduction Grant (VIG) $1,204,720 $1,204,720 $714,000 59%
Yellow Fever (NVS) $5,212,815 $5,212,815 $5,537,582 106%

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Chad DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2015)

Grade of confidence


N/A
DTP3 - Official country estimates (2015) 92%
M:F sex ratio at birth (2017) 1.03
Household survey: DTP3 coverage for male (2014) 32.60%
Household survey: DTP3 coverage for female (2014) 33.80%
Household survey: Last DTP3 survey (2014) 33%
% districts achieving > 80% DTP3 coverage (2015) 60%
% districts achieving < 50% DTP3 coverage (2015) 11%
MCV WHO/UNICEF estimates (2015) 62%

Breakdown of support

Non-vaccine support Vaccine support
25% 75%
$15,408,128 $46,474,744

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Chad

19 September 2016

Stockpiling

On the frontline: Gavi's support to fragile states

With more than half of Gavi-supported countries officially listed as fragile states, Gavi is increasingly working on several fronts to ensure vaccines still reach people living on the frontlines of humanitarian crises.

22 February 2016

Gavi item

Meningitis A nearly eliminated in Africa through vaccination

Joint press release first published by WHO and PATH, joint founders of the Meningitis Vaccine Project.

10 November 2015

Gavi item

Scientists mark 'stunning success' of vaccine in virtually ridding Africa of meningitis A

New research forecasts a resurgence of meningitis A epidemics in 15 years should immunization efforts stall.

close icon

modal window here